The spectrum of nodular lymphocyte predominant Hodgkin lymphoma: a report of the lymphoma workshop of the 20th meeting of the European Association for Haematopathology

Virchows Arch. 2023 Oct;483(4):451-463. doi: 10.1007/s00428-023-03554-1. Epub 2023 Aug 2.

Abstract

Session 4 of the 2021 European Association of Haematopathology/Society for Hematopathology Workshop focused on nodular lymphocyte predominant Hodgkin lymphoma (NLPHL). First, the spectrum of immunophenotypic variations in NLPHL and the defining criteria for classic Hodgkin Lymphoma (CHL) were discussed. The added value of further immunophenotypic characterization of both tumor cells and microenvironment to support the differential diagnosis was presented. Next, unusual cases with combined growth patterns and evolution of morphological features over time were presented to explore the clinicopathological impact of presumed high-risk patterns. Based on a large collection of cases, the defining morphological, immunophenotypical, and gene expression features of T-cell/histiocyte-rich large B-cell lymphoma (THRLBCL) and THRLBCL-like NLPHL (pattern E) were reviewed to explore this challenging differential diagnosis and critically evaluate whether aggressive behavior and transformation of NLPHL can be predicted in practice.

Keywords: Diagnostic workshop; Gene expression profiling; Immune microenvironment; Nodular lymphocyte predominant Hodgkin Lymphoma; T-cell/histiocyte-rich large B-cell lymphoma.

Publication types

  • Review

MeSH terms

  • Diagnosis, Differential
  • Hodgkin Disease* / diagnosis
  • Hodgkin Disease* / pathology
  • Humans
  • Immunophenotyping
  • Lymphoma, Large B-Cell, Diffuse* / pathology
  • T-Lymphocytes / metabolism
  • Tumor Microenvironment